Searcharxiv⌕ Search

arXiv subjects

Narges Ramezani

Publications and source records attributed to Narges Ramezani.

2 recordsLinked to original sources

The Role of Public Health in the Fight Against Cancer: Awareness, Prevention, and Early Detection

Cancer, as a complex and devastating sickness, poses a great public health challenge on a global scale. Its far-attaining impact necessitates a devoted branch of medicine referred to as oncology, which makes a specialty in the prevention, diagnosis, and treatment of cancer. In this paper, we aim to offer a complete evaluation of the oncology sector, delving into its rich history, numerous forms of most cancers, diagnostic methods, and treatment alternatives. By exploring recent advances in oncology, which include precision remedy, immunotherapy, and the integration of era, we shed mild on the promising traits of the subject. However, it is miles essential to know the continual challenges that we face, such as the high costs related to remedy and the emergence of drug resistance. Despite these challenges, the final goal of oncology remains unwavering - to provide exceptional feasible outcomes for sufferers of most cancers, using both healing and palliative remedy strategies. As our knowledge of this complicated ailment continues to adapt, we must prioritize prevention and early detection and deal with disparities in access to care. By fostering collaboration and operating collectively, we can seriously improve the lives of tens of millions of individuals affected by cancer around the arena.

q-bio.TO↗

Managing Biotechnology and Healthcare Innovation Challenges and Opportunities for Startups and Small Companies

The biotechnology industry poses challenges and possibilities for startups and small businesses. It is characterized by high charges and complex policies, making it difficult for such agencies to set up themselves. However, it additionally offers avenues for innovation and increase. This paper delves into powerful techniques that can be a resource in managing biotechnology innovation, which includes partnerships, highbrow assets improvement, virtual technologies, customer engagement, and government investment. These strategies are important for fulfillment in an industry that is constantly evolving. By embracing agility and area of interest focus, startups and small companies can successfully compete in this dynamic discipline.

econ.GN↗